SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013429
Filing Date
2024-04-26
Accepted
2024-04-26 16:21:09
Documents
21
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A eton20240318_def14a.htm   iXBRL DEF 14A 498584
6 bodchartimage2024.jpg GRAPHIC 22222
7 image01.jpg GRAPHIC 2465
8 image04.jpg GRAPHIC 29583
9 image05.jpg GRAPHIC 44948
10 image06.jpg GRAPHIC 87672
11 image07.jpg GRAPHIC 57180
12 image08.jpg GRAPHIC 50844
  Complete submission text file 0001437749-24-013429.txt   1644127

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eton-20231231.xsd EX-101.SCH 2743
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20231231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20231231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20231231_pre.xml EX-101.PRE 714
24 EXTRACTED XBRL INSTANCE DOCUMENT eton20240318_def14a_htm.xml XML 50146
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38738 | Film No.: 24884123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)